Company : BioSphere Medical Inc
UMDC Code : 451630
Microspheres were cleared by the FDA in April 2000 for marketing in the U.S. for hypervascularized tumors and arteriovenous malformations. Embolotherapy works by reducing blood flow to target areas of the body. The procedure is performed by injecting agents, usually particles, through a catheter and into the blood vessels that feed these target areas. By selectively blocking the target tissues blood supply, the deprived tissue will either be destroyed or become devitalized, resulting in therapeutic benefit.
Product URL : http://www.biospheremed.com/products/embosphere.cf
Last Updated : 03/16/2013